| Aaron, Shawn |
| Not yet recruiting | 4 | 48 | NA | LABA+LAMA, Anoro Ellipta, LABA+LAMA+ICS, Trelegy Ellipta, Filtered Air, Diesel Exhaust, Traffic Related Air Pollution | University of British Columbia, University of Calgary, University of Ottawa, University of Manitoba, University of North Carolina, Chapel Hill | COPD | 12/26 | 12/28 | | |
| Active, not recruiting | N/A | 1500 | Canada | | McGill University Health Centre/Research Institute of the McGill University Health Centre, Canadian Institutes of Health Research (CIHR), GlaxoSmithKline, AstraZeneca, Pfizer, Boehringer Ingelheim, Novartis, Takeda, Merck Sharp & Dohme LLC, Almirall, SAS | COPD, Chronic Obstructive Pulmonary Disease | 12/22 | 12/22 | | |
NCT05181670: The Canadian Respiratory Research Network Long COVID-19 Study |
|
|
| Enrolling by invitation | N/A | 650 | Canada | | Sunnybrook Health Sciences Centre, Canadian Institutes of Health Research (CIHR) | SARS-CoV-2 Infection, Post-acute Sequelae of SARS-CoV-2 | 08/24 | 12/24 | | |
| Recruiting | N/A | 714 | Canada | | University of British Columbia, University of Alberta, University of Toronto, Laval University, McGill University, Université de Sherbrooke, The Ottawa Hospital, Queen's University, University of Saskatchewan, Western University, Canada | Severe Asthma | 12/27 | 12/28 | | |
UCAP2, NCT06392776: Early Diagnosis and Treatment of Undiagnosed Asthma or COPD: THE UCAP 2 TRIAL |
|
|
| Recruiting | N/A | 420 | Canada | Early diagnosis and treatment | Ottawa Hospital Research Institute | COPD, Asthma | 12/28 | 12/29 | | |
| Withdrawn | N/A | 200 | Canada | Assessment and Treatment provided to participant by a respirologist using evidence-based guidelines for asthma or COPD | Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR) | COPD, Asthma | 12/27 | 12/28 | | |
| Watpool, Irene |
| Recruiting | 4 | 856 | Canada | 20-25% Albumin fluid (100 mL), 0.9% Normal Saline (100 mL) | Ottawa Hospital Research Institute, The Physicians' Services Incorporated Foundation, The Kidney Foundation of Canada, The Ottawa Hospital Academic Medical Organization (TOHAMO) Innovation Fund Grant., Canadian Institutes of Health Research (CIHR), Canadian Blood Services, Héma-Québec | Acute Kidney Injury, Renal Replacement Therapy, Hypotension, Critical Illness | 08/25 | 10/25 | | |
SAVE-ICU, NCT04415060: SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival |
|
|
| Recruiting | 3 | 800 | Canada | Isoflurane Inhalant Product, Sevoflurane inhalant product | Sunnybrook Health Sciences Centre | Covid19, Hypoxic Respiratory Failure | 03/26 | 06/27 | | |
| Recruiting | 2 | 80 | NA | Therapeutic Plasma Exchange | University of Manitoba, Canadian Institutes of Health Research (CIHR), Health Sciences Centre Foundation, Manitoba, McMaster University, University of Toronto | Septic Shock | 03/26 | 12/26 | | |
| Recruiting | 2 | 296 | Canada | Allogeneic umbilical cord-derived human mesenchymal stromal cells, Placebo | Ottawa Hospital Research Institute, Canadian Institutes of Health Research (CIHR), Stem Cell Network, Canadian Critical Care Trials Group, Technische Universität Dresden | Septic Shock, Sepsis, Pathologic Processes, Shock, Systemic Inflammatory Response Syndrome, Inflammation, Infections | 09/26 | 03/27 | | |
MitoHIRRT, NCT05264285: Mitochondrial Health and Hemodynamic Instability Related to Renal Replacement Therapy in Critically Ill Patients |
|
|
| Recruiting | N/A | 60 | Canada | | Ottawa Hospital Research Institute, University of Ottawa, University of Helsinki | Acute Kidney Injury (AKI) | 12/23 | 09/24 | | |
